Veracyte, Inc. (VCYT) on GreekSoup https://greeksoup.ai/stocks/us/vcyt/ Every dated entry in the public record on Veracyte, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Veracyte, Inc.: short interest 10,178,975 shares at the 30 September 2026 settlement, 5.88 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-09-30:f29d0b372cWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, JENS HOLSTEIN plans to sell 7,500 shares worth $352,500 around 24 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-24:d2d283a80cThu, 24 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Leite John (Global Chief Commercial Off) sold 4,015 shares at $40.00 on 21 September 2026, $160,600https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-22:7b8f1a23abTue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, JOHN LEITE plans to sell 4,015 shares worth $159,777 around 21 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-21:f85551c1dcMon, 21 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Holstein Jens (Director) sold 5,000 shares at $40.95 on 14 September 2026, $204,747https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-16:2b17988754Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: short interest 8,403,932 shares at the 15 September 2026 settlement, 7.76 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-09-15:5541371af9Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Veracyte, Inc. filed 8-K: material agreement, acquisition or disposition completed, regulation fd disclosurehttps://greeksoup.ai/stocks/us/vcyt/filings/us:VCYT:filing:2026-09-14:66f2846b24Mon, 14 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, JENS HOLSTEIN plans to sell 5,000 shares worth $204,747 around 14 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-14:e92896d68eMon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, ANN MCGUIRE plans to sell 3,254 shares worth $145,356 around 4 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-04:2c025ce6a7Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, REBECCA CHAMBERS plans to sell 3,652 shares worth $163,135 around 4 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-04:8648eab7f4Fri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, PHILLIP FEBBO plans to sell 13,110 shares worth $585,624 around 4 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-04:d35e732e7aFri, 04 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Febbo Phillip G. (Chief Scientific & Med Officer) sold 10,405 shares at $42.89 on 4 September 2026, $446,305https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:b4c86d9dccFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Febbo Phillip G. (Chief Scientific & Med Officer) sold 2,705 shares at $43.66 on 4 September 2026, $118,105https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:fa05373c1dFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Chambers Rebecca (Chief Financial Officer) sold 2,477 shares at $42.81 on 4 September 2026, $106,030https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:5713e3ca77Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Chambers Rebecca (Chief Financial Officer) sold 1,175 shares at $43.71 on 4 September 2026, $51,364https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:3ba14f6834Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Mcguire Annie (EVP, General Counsel) sold 2,154 shares at $42.79 on 4 September 2026, $92,173https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:1e2735e02cFri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Mcguire Annie (EVP, General Counsel) sold 1,100 shares at $43.67 on 4 September 2026, $48,039https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-04:c750e42e30Fri, 04 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Bhanji Muna (Director) sold 1,864 shares at $42.97 on 1 September 2026, $80,096https://greeksoup.ai/stocks/us/vcyt/insiders/us:VCYT:insider:2026-09-03:a35d86e66dThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: Form 144, MUNA BHANJI plans to sell 3,728 shares worth $161,012 around 1 September 2026https://greeksoup.ai/stocks/us/vcyt/planned-sales/us:VCYT:planned-sale:2026-09-01:d0ec90951fTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: short interest 8,077,228 shares at the 31 August 2026 settlement, 5.84 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-08-31:b04548dfafMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: short interest 6,789,714 shares at the 14 August 2026 settlement, 5.60 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-08-14:28dcd06fc3Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Veracyte, Inc. Q2 FY2026 results: revenue $150 million, net income $25 millionhttps://greeksoup.ai/stocks/us/vcyt/results/fy2026-q2/us:VCYT:result:2026-07-31:68fb099c4dFri, 31 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Veracyte, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/vcyt/filings/us:VCYT:filing:2026-07-31:cf0bc6c821Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: short interest 6,858,686 shares at the 31 July 2026 settlement, 4.81 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-07-31:ebeadb1114Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Veracyte, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/vcyt/filings/us:VCYT:filing:2026-07-30:1701513de1Thu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Veracyte, Inc.: short interest 6,674,331 shares at the 15 July 2026 settlement, 6.75 days to coverhttps://greeksoup.ai/stocks/us/vcyt/short-interest/us:VCYT:short-interest:2026-07-15:ba663b0b0aWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>